These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33651085)

  • 1. Antiretroviral Drug Recommendations for HIV Treatment and Prevention.
    Shalev N; Brudney KF; Scherer ML
    JAMA; 2021 Mar; 325(9):888-889. PubMed ID: 33651085
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral Drug Recommendations for HIV Treatment and Prevention-Reply.
    Saag MS; Gandhi RT; Sax PE
    JAMA; 2021 Mar; 325(9):889-890. PubMed ID: 33651088
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
    Krogstad PA
    J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretrovirals for HIV prevention: when should they be recommended?
    Kiselinova M; De Spiegelaere W; Verhofstede C; Callens SF; Vandekerckhove L
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):431-45. PubMed ID: 24621251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies.
    Jacobs TG; Schouwenburg S; Penazzato M; Archary M; Ruel TD; van den Anker J; Burger DM; Cressey TR; Abrams EJ; Lyall H; Bekker A; Colbers A; ;
    Lancet HIV; 2022 Sep; 9(9):e649-e657. PubMed ID: 35863363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who will bridge the HIV treatment-prevention gap?
    Weis P; Schmid G; De Cock K
    J Infect Dis; 2008 Jul; 198(2):293-4. PubMed ID: 18593296
    [No Abstract]   [Full Text] [Related]  

  • 7. Weighing the risk of drug resistance with the benefits of HIV preexposure prophylaxis.
    Grant RM; Liegler T
    J Infect Dis; 2015 Apr; 211(8):1202-4. PubMed ID: 25587019
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiretroviral treatment for HIV: is it time for 2 drug regimens?].
    Heiken H
    MMW Fortschr Med; 2019 Jun; 161(Suppl 2):42-46. PubMed ID: 31175589
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel antiretroviral agents and universal access to HIV care.
    Boyd MA; Cooper DA
    Lancet HIV; 2016 Jan; 3(1):e2-3. PubMed ID: 26762989
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-retrovirals for treatment and prevention--time for new paradigms in our response to the HIV/AIDS epidemic?
    Abdool Karim Q; Bayer R
    Dev World Bioeth; 2013 Aug; 13(2):ii-iii. PubMed ID: 23865982
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiretroviral therapy in 2004].
    Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New horizons in the pharmaceutical care of HIV patients on long-term antiretroviral treatment.
    Gimeno-Gracia M; Antela A
    Farm Hosp; 2021 Nov; 45(6):287-288. PubMed ID: 34806568
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on antiretroviral treatment during primary HIV infection.
    Ambrosioni J; Nicolas D; Sued O; Agüero F; Manzardo C; Miro JM
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):793-807. PubMed ID: 24803105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The introduction of antiretroviral therapy in Malawi].
    Sanders CJ
    Ned Tijdschr Geneeskd; 2007 Mar; 151(9):560. PubMed ID: 17373399
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Badri et al. on 'Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis'.
    Trikalinos TA; Panidou ET; Ioannidis JP
    AIDS; 2005 Aug; 19(12):1336-7. PubMed ID: 16052096
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiretroviral therapy in Africa.
    Stevens W; Kaye S; Corrah T
    BMJ; 2004 Jan; 328(7434):280-2. PubMed ID: 14751902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral Drugs as the Linchpin for Prevention of HIV Infections in the United States.
    Samandari T; Harris N; Cleveland JC; Purcell DW; McCray E
    Am J Public Health; 2017 Oct; 107(10):1577-1579. PubMed ID: 28902548
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral therapy in the developing world.
    Chulamokha L; DeSimone JA; Pomerantz RJ
    J Neurovirol; 2005; 11 Suppl 1():76-80. PubMed ID: 15960241
    [No Abstract]   [Full Text] [Related]  

  • 20. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.